ArticleNature medicine2025

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.

Anna M Varghese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.